Pharming signs licensing agreement with Aslan Group.....           AstraZeneca appoints new president of US business.....           BioReliance signs manufacturing agreement with Provecs Medical.....           Accera to launch Axona in US for Alzheimer's disease.....           Allion Healthcare and Under One Roof form partnership.....           Mylan wins FDA approval for fluoxetine capsules.....           TorreyPines licenses Posiphen, bisnorcymcerine and phenserine to QR Pharma.....           Wellesse launches liquid Vitamin D3.....           Icon and Lilly sign agreement to manage clinical data management business.....           Metabolex reports positive results from Phase II dyslipidemia trial.....           CytoGenix names new president and CEO.....           UCB reports positive results from two Phase III arthritis trials.....           Salix granted new US patent for rifaximin.....           Encorium signs new business contracts worth $6.5 million.....           Chelsea completes enrollment for Phase II hypotension trial.....           Teva and Active Biotech complete enrollment for Phase III MS trial.....           Genzyme and ICGEB form collaboration.....           SuperGen names new chief scientific officer.....           Salient Surgical names new vice president of human resources.....           Thallion initiates enrollment for Phase II melanoma trial.....           NeuroNexus and Philips sign research agreement.....           Lilly and United Therapeutics sign license and supply agreement.....           United Therapeutics's oral PAH trial fails primary endpoint.....           Abingdon Life Sciences extends alliance with Stason Pharmaceuticals.....           Sorin Group and Sphere Medical sign development agreement.....           Patheon and Senopsys form alliance.....           MedX signs manufacturing and distribution agreement with Naimco/Rich-Mar.....           Mylan's ANDA wins FDA approval for depression drug.....           Life Science Pharmaceuticals signs licensing agreement with Abbott.....           ZyGEM and VWR International sign distribution agreement.....           Provectus adds sixth center to Phase II melanoma trial.....           Global Med Technologies names new CFO.....           St Jude Medical wins Japanese approval for Victory pacemakers.....           InteRNA Technologies and Cenix BioScience sign research agreement.....           Ascent Therapeutics names new CEO and head of discovery research.....           Innocoll wins FDA fast track designation for Gentamicin surgical implant.....           Sequenom acquires clinical diagnostics laboratory.....           Proteo initiates patient recruitment for Phase II carcinoma trial.....           Cardiac Dimensions names new vice president of R&D.....           Sol Gel Technologies raises $9 million in financing.....           Vernalis appoints new CEO and CFO.....           Daiichi Sankyo initiates clinical studies of anti-influenza drug.....           Generex and Shreya Life introduce oral insulin in India.....           Neurogen divests non-core assets.....           Genaera's Q3 net loss narrows.....           Nanosonics appoints European distributors for infection control product.....           Midatech establishes new drug development subsidiary in Switzerland.....           Boehringer Ingelheim advances cancer drug to Phase III studies.....           Stem Cell Sciences announces validation of European IRES technology patent.....           Viacor initiates treatment in heart failure study.....           Joshua Partners acquires Medicia.....           AnaSpec opens new GMP manufacturing facility.....           Javelin Pharmaceuticals to reduce workforce by 15%.....           Solos Endoscopy introduces Mammo View system in Puerto Rico.....           Patheon and Solvias partner to offer integrated development services.....           Harvard Bioscience names new CFO.....           Sirius Genomics names three new board members.....           Mortara extends ECG Warehouse CRADA with FDA.....           Pfizer launches new stem cell research unit.....           Bioanalytical Systems names new COO of scientific services.....           Genetic Immunity initiates dosing for Phase II HIV trial.....           Zoll and Masimo sign technology agreement.....           Amag's ferumoxytol resubmission designated complete, class 1 Response by FDA.....           BioForce Nanosciences signs collaboration agreement with UPMC and CNRS.....           Watson's Trelstar NDA accepted for filing by FDA.....           TheraQuest's IND for abuse deterrent opioid accepted by FDA.....           Curis's collaborator Genentech grants ex-US rights of cancer drug to Roche.....           Zoll signs purchasing agreement with HealthTrust.....           ADMETRx and Roche form collaboration.....           Review Of Laboratory Animal Protection; Directive Needs To Balance........           Watson Announces the NDA for a 6-Month Formulation of Trelstar........           Quigley Pharma to complete Phase IIb diabetic peripheral neuropathy study.....           Intelect Medical closes financing deal with Boston Scientific and Greatbatch.....           Pfizer reports positive findings from sub-analysis of Lipitor study.....           ThromboGenics announces six month results of Phase IIb visual disorders trial.....           Ambrx announces positive data from Phase I/II AGHD study.....           Bayer pledges E1.5 million support for hemophilia treatment centers in China.....           MedImmune names new president.....           CVBT signs clinical development agreement with Cardio Neo-Genesis.....           Medtronic acquires CryoCath Technologies.....           Lexicon Pharmaceuticals completes Phase I carcinoid syndrome trial.....           Chelsea initiates dosing for Phase I study of anti-inflammatory drug.....           Perrigo acquires Unico Holdings.....           Inotek Pharmaceuticals granted two new US patents.....           Wyeth wins FDA approval for new indication of Premarin vaginal cream.....           Theratechnologies completes Phase III HIV-associated lipodystrophy study.....           Delphi Genetics signs collaboration agreement with Eurogentec Biologics.....           Affymax completes enrollment for Phase III anemia trial.....           China Sky One Medical wins production rights for nine new drugs.....           Redpoint Bio signs pharmaceutical research agreement with Schering.....           Sigma-Aldrich signs distribution agreement with AlphaGenix.....           Teva to Present at the 2008 Credit Suisse Annual Healthcare Conference.....           Patheon Launches Quick To Market(SM) Program to Industry.....           BioLineRx and Yissum sign licensing agreement.....           Phosphagenics initiates Phase I study of anti-inflammatory drug.....           OctoPlus obtains new drug delivery evaluation contract.....           Amedica wins CE Mark for Valeo ceramic spinal implant system.....           Metabolex reports positive results from Phase Ia study of diabetes drug.....           TorreyPines Therapeutics names new CEO.....           K2M acquires rights to PSD's injectable polymer technology.....           AEterna Zentaris to sell Cetrotide royalty stream to CHRP.....           PharmaVigilant launches electronic capture database for Phase I/II cancer study.....           CVS Caremark names new executive vice president and chief medical officer.....           GSK commences tender offer to acquire Genelabs Technologies.....           Basilea's new anti-MRSA antibiotic wins Swiss approval.....           Acorda names new chief medical officer.....           AstraZeneca's Seroquel wins European approval for new indications.....           Icon establishes new facility in India.....           Diamyd Medical announces European patent for treatment of erectile dysfunction.....           UPMC and GE Healthcare partner to develop international oncology centers.....           Nyer Medical's subsidiary signs pharmacy service agreement.....           Ferring names new vice president of orthopedics and urology business unit.....           Marshall Edwards's Phase III ovarian cancer trial wins positive review.....           Haptoglobin genotype testing plays key role in diabetes therapy, says Synvista.....           ImClone initiates enrollment in Phase II lung cancer trial.....           Cell Therapeutics's Phase III lymphoma trial meets primary endpoint.....           Irvine Pharmaceutical Services to launch Avrio Biopharmaceuticals.....           SCS licenses its stem cell technology for pharmaceutical research.....           OIT acquires Toshiba Aplio artida 4D ultrasound system.....           Intellect validates European patent for Alzheimer's antibody platform.....           GenVec's TNFerade wins fast track designation for pancreatic cancer treatment.....           Ekr Therapeutics wins FDA approval for double concentration premixed IV bags.....           Alba Therapeutics initiates enrollment in Phase IIb celiac disease study.....           Alexion's president to retire.....           Accumetrics names new chief medical officer.....           Raptor reports promising results from Phase IIa ALDH2 deficiency study.....           Patheon Launches Quick To Clinic(SM) Program: Goal Is To Reduce Development Time for Customers.....           Camargo Hires Lynn Gold, PhD, Vice President of CMC Services.....           Sanofi's polio vaccine selected for immunization program in Russia.....           Biovitrum and Wyeth extend supply agreement.....           Marillion and Bracco Imaging sign licensing agreement.....           Novexel initiates Phase II urinary tract infections trial.....           Compugen names new president and CEO.....           CytRx reports encouraging results from Phase I leukemia study.....           Cynvec names new president and CEO.....           Razadyne generic wins FDA approval.....           KV Pharmaceutical to File Form 12b-25 on November 12, 2008.....           GSK Will Overtake Pfizer To Become World's Largest Pharmaceutical Company By 2012 - URCH Publishing.....           Endocare and Galil Medical sign merger agreement.....           Sangamo reports top-line data from Phase II diabetic neuropathy trial.....           3SBio files for Chinese approval of kidney cancer drug.....           Anesiva's pain drug fails endpoint in Phase III study.....           Amylin announces restructuring, cuts 340 jobs.....           Lorus completes IND-enabling toxicology studies for cancer drug.....           Advinus Therapeutics launches US operations.....           NuPathe names new vice president and CFO.....           Xoma restructures drug development collaboration with Novartis.....           Arbor Vita signs collaboration and licensing agreement with BD.....           Celgene wins FDA clearance for Phase I placenta-derived stem cell study.....           Pharmasset announces initiation of hepatitis antiviral combination study.....           Integrated BioPharma names new president and CEO.....           Azur Pharma and Elan collaborate to develop once-daily clozapine.....           Adeona granted new US patent for oral tiomolibdate diammonium.....           Boston Scientific wins FDA approval for Apex PTCA dilatation catheter.....           TorreyPines sells Alzheimer's disease genetics program to Eisai.....           GSK and XenoPort withdraw new drug application for RLS drug.....           Targeted Genetics names new president and CEO.....           Qiagen launches new molecular assay.....            
 

“Skin Forum 2008"
25th - 27th June 2008
School of Pharmacy, University of  London
What would you like to do?


Contact Dr. M.E. Lane majella.lane@btinternet.com for further details

 

 PLEASE MARK THIS DATE IN YOUR DIARY

Registered in England. No 4245751. Registered Office: 840 Melton Road, Thurmaston, Leicester, LE4 8BN